Skip to main content
logo
Vita Life Sciences Limited (ASX:VLS)
Australia flag Australia · Delayed Price · Currency is AUD
2.780
+0.040 (1.46%)
Aug 21, 2026, 4:10 PM AEST

Vita Life Sciences Revenue

Vita Life Sciences had revenue of 47.73M AUD in the half year ending December 31, 2025, with 22.42% growth. This brings the company's revenue in the last twelve months to 96.03M, up 12.19% year-over-year. In the year 2025, Vita Life Sciences had annual revenue of 93.27M with 17.31% growth.

Revenue (ttm)
96.03M
Revenue Growth
+12.19%
P/S Ratio
1.63
Revenue / Employee
274.37K
Employees
350
Market Cap
156.74M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202593.27M13.77M17.31%
Dec 31, 202479.51M6.08M8.28%
Dec 31, 202373.43M6.54M9.78%
Dec 31, 202266.89M9.78M17.14%
Dec 31, 202157.10M10.62M22.85%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Vitura Health129.24M
Little Green Pharma75.50M
Medical Developments International40.64M
ECS Botanics Holdings20.97M
IDT Australia20.53M
Peak Processing14.59M
Cann Group11.31M
Epsilon Healthcare9.39M
Revenue Rankings

Vita Life Sciences News

More News